DocMorris AG (ZRSEF)
USD 21.6
(-40.36%)
USD 21.6
(-40.36%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 203.34 Million CHF | -18.26% |
| 2022 | 245.62 Million CHF | -5.54% |
| 2021 | 260.04 Million CHF | 7.75% |
| 2020 | 241.33 Million CHF | 15.66% |
| 2019 | 208.65 Million CHF | 9.12% |
| 2018 | 191.21 Million CHF | 30.45% |
| 2017 | 146.57 Million CHF | 11.11% |
| 2016 | 131.92 Million CHF | 4.96% |
| 2015 | 125.69 Million CHF | -10.02% |
| 2014 | 139.68 Million CHF | 0.85% |
| 2013 | 138.51 Million CHF | 84.16% |
| 2012 | 75.21 Million CHF | 5.23% |
| 2011 | 71.47 Million CHF | -1.03% |
| 2010 | 72.21 Million CHF | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 53.62 Million CHF | 0.0% |
| 2024 Q1 | 53.62 Million CHF | 73.8% |
| 2023 Q3 | 51.7 Million CHF | 175.18% |
| 2023 Q2 | 18.79 Million CHF | -62.4% |
| 2023 FY | 200.78 Million CHF | -18.26% |
| 2023 Q1 | 49.96 Million CHF | 320.39% |
| 2023 Q4 | 30.85 Million CHF | -40.33% |
| 2022 Q3 | 40.18 Million CHF | 158.99% |
| 2022 FY | 245.62 Million CHF | -5.54% |
| 2022 Q1 | 39.89 Million CHF | 55.69% |
| 2022 Q2 | 15.51 Million CHF | -61.1% |
| 2022 Q4 | 11.88 Million CHF | -70.42% |
| 2021 Q2 | 34.93 Million CHF | -48.35% |
| 2021 FY | 260.04 Million CHF | 7.75% |
| 2021 Q1 | 67.63 Million CHF | 159.71% |
| 2021 Q4 | 25.62 Million CHF | -58.93% |
| 2021 Q3 | 62.38 Million CHF | 78.6% |
| 2020 Q3 | 59.97 Million CHF | 81.02% |
| 2020 FY | 241.33 Million CHF | 15.66% |
| 2020 Q4 | 26.04 Million CHF | -56.57% |
| 2020 Q2 | 33.12 Million CHF | -45.42% |
| 2020 Q1 | 60.69 Million CHF | 109.33% |
| 2019 FY | 208.65 Million CHF | 9.12% |
| 2019 Q1 | 52.39 Million CHF | 11.27% |
| 2019 Q2 | 30.29 Million CHF | -42.18% |
| 2019 Q4 | 28.99 Million CHF | -44.16% |
| 2019 Q3 | 51.92 Million CHF | 71.4% |
| 2018 Q2 | 48.51 Million CHF | 0.0% |
| 2018 FY | 191.21 Million CHF | 30.45% |
| 2018 Q1 | 48.51 Million CHF | 18.01% |
| 2018 Q4 | 47.08 Million CHF | 0.0% |
| 2018 Q3 | 47.08 Million CHF | -2.94% |
| 2017 Q2 | 36.58 Million CHF | 3.67% |
| 2017 Q1 | 35.29 Million CHF | 3.51% |
| 2017 FY | 146.57 Million CHF | 11.11% |
| 2017 Q4 | 41.11 Million CHF | 0.0% |
| 2017 Q3 | 41.11 Million CHF | 12.37% |
| 2016 Q4 | 34.09 Million CHF | 0.0% |
| 2016 Q3 | 34.09 Million CHF | -0.18% |
| 2016 Q2 | 34.15 Million CHF | 0.82% |
| 2016 Q1 | 33.87 Million CHF | -27.28% |
| 2016 FY | 131.92 Million CHF | 4.96% |
| 2015 Q1 | 18.27 Million CHF | -16.33% |
| 2015 Q4 | 46.58 Million CHF | 0.0% |
| 2015 Q3 | 46.58 Million CHF | 154.9% |
| 2015 FY | 125.69 Million CHF | -10.02% |
| 2015 Q2 | 18.27 Million CHF | 0.0% |
| 2014 Q2 | 21.49 Million CHF | 0.0% |
| 2014 Q1 | 21.49 Million CHF | 8.26% |
| 2014 Q4 | 21.84 Million CHF | 0.0% |
| 2014 FY | 139.68 Million CHF | 0.85% |
| 2014 Q3 | 21.84 Million CHF | 1.6% |
| 2013 Q2 | 21.59 Million CHF | 0.0% |
| 2013 Q3 | 19.85 Million CHF | -8.05% |
| 2013 Q4 | 19.85 Million CHF | 0.0% |
| 2013 FY | 138.51 Million CHF | 84.16% |
| 2013 Q1 | 21.59 Million CHF | 0.0% |
| 2012 FY | 75.21 Million CHF | 5.23% |
| 2011 FY | 71.47 Million CHF | -1.03% |
| 2010 FY | 72.21 Million CHF | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 134.07 Million USD | -51.663% |
| Café Serendipity Holdings, Inc. | 1196.00 USD | -17002241.137% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | - USD | -Infinity% |
| HealthWarehouse.com, Inc. | 12.17 Million USD | -1570.358% |
| LIGAND PHARMACEUTICAL INC | 88.02 Million USD | -131.009% |
| MedGen, Inc. | 1.05 USD | -19366476090.476% |
| Omni Health, Inc. | 1.55 Million USD | -12997.737% |
| Oxford Investments Holdings Inc. | 31.45 Thousand USD | -646311.088% |
| Pineapple, Inc. | -1.02 Million USD | 19944.792% |
| ScripsAmerica, Inc. | 27.59 Million USD | -636.846% |